Exchange: NASDAQ·Updated 06:51 PM EDT
BIOX logo

BIOX Bioceres Crop Solutions Corp

$0.3283
$0.0001
(0.03%)
Today
Closed $0.3283
$0.00
(0.00%)
After Hours
Reported EarningsSep 14
Mkt Cap$20.75M
Vol127,763.00

About BIOX

Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The firm includes seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers. It operates through the following segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment deals with the development and commercialization of integrated products that combine three complementary components biotechnological events, germplasm and seed treatments in order to increase crop productivity and create value for customers. The Crop Protection segment develops and produces adjuvants, insecticides and fungicides. The Crop Nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops and of fertilizers including bio fertilizers and micro granulated fertilizers that increases the productivity and yield of the crops. The company was founded on November 14, 2017 and is headquartered in Rosario, Argentina.
59

Bullish Sentiment

How do you feel about BIOX?

LegalEagles
$BIOX 6k today acknowledges loss of summary judgment on damages, but forgets to state amount: $100 million+. Once the Jasper lenders have an executable judgment in hand (likely as soon as this week), they can essentially shut BIOX down by garnishing their accounts. Unless there is a mystery angel willing to lend BIOX $108M to post an appellate undertaking (and thus stay execution of the judgment), BK seems inevitable in a matter of days.
1
LegalEagles
$BIOX Jasper lenders have begun enforcement efforts, per a company filing in the lawsuit seeking a stay (though $BIOX still can't find anyone to post an appellate bond). Restraining notices have gone out to various U.S. subs, and the company states in its papers that enforcement will almost certainly "leave Defendants' balance sheet insolvent" and may force them "to seek bankruptcy protection." Money quote: "Seized assets, frozen accounts, and disrupted operations would quickly cause employee departures, contract terminations, loan defaults...[and] trigger the insolvency cascade."
LegalEagles
$BIOX UPDATE: The New York court issued a final executable judgment against the company last Friday, for about $110.5 million. No 6k yet. It's up the lender whether they want to start to garnish/levy U.S. accounts (thus tipping the co into BK), or negotiate what I would think would be a *massive* equity dilution.
StocktwitsEarnings
$BIOX Q4 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.39 up 48.68% YoY • Reported revenue of $56M down -24.93% YoY
focafoca99
$BIOX released FY2026 and Q4 results, noting stable Q4 revenue and a move to positive Adjusted EBITDA.

Advertisement|Remove ads.